Author

Estefani Diaz

Northwestern UniversityORCID 0000-0003-4146-0276Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexander V. MishariniD· 2 shared Ankit BharatiD· 2 shared Cara J. GottardiiD· 2 shared Elizabeth S. MalsiniD· 2 shared Emmy JonassoniD· 2 shared G. R. Scott BudingeriD· 2 shared Hiam Abdala‐ValenciaiD· 2 shared Jane E. DematteiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alexander V. MisharinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 7, 2025

Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease

Nikolay S. Markov, Anthony Joseph Esposito, Karolina J. Senkow…·Monique Hinchcliff

The paper identifies profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in SSc-ILD by analyzing BAL fluid and lung explants.

6 citations

humanflow cytometry

𝕏 PostBluesky

Systems BiologyNature ImmunologyPeer-reviewedAug 13, 2024

A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia

Nikolay S. Markov, Ziyou Ren, Karolina J. Senkow…·Karen M. Ridge

The paper examines alveolar T cell responses in SARS-CoV-2 pneumonia patients, finding that early interferon signaling and targeting of structural proteins correlate with better clinical outcomes.

17 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky